
Pulmonology
Cystic Fibrosis: A Paradigm Treatment Shift is Underway
Columbia University pulmonologists conducts clinical trial on novel triple combination modulator for cystic fibrosis in patients with advanced lung disease, demonstrating progressive improvement in weight, lung function, and patient-reported outcomes.